Background/aim
The main aim of the study is to assess expression levels of
CDH1
,
FHIT
,
PTEN
, and
TTPAL
genes in tumors and peripheral bloods of colorectal cancer patients in staged I–IV.
Materials and methods
Gene expression analysis of related genes were performed for tumor tissues and peripheral blood samples of 51 colorectal cancer patients and colon tissues and blood samples of 5 healthy individuals. The real-time-PCR reaction method was used for the analysis.
Results
Alteration of mRNA levels of related genes in tumor tissues of colorectal cancer cases was determined compared to control tissues.
GAPDH
and
TBP
were used for the normalization. While the mRNA levels of
CDH1
decreased, the mRNA level of the
FHIT
and
TTPAL
genes increased in the tumor tissues. There was no
PTEN
gene expression difference in tumor tissues (total). The mRNA levels of the
CDH1
and
PTEN
genes were increased while the mRNA levels of
FHIT
and
TTPAL
genes decreased in the blood (total). The mRNA levels of the
CDH1 g
ene decreased at each stage (I–IV) in the tumor tissues and increased at each stage (I–IV) in the blood. The
PTEN
gene mRNA levels at each stage were controversial. The mRNA levels of the
FHIT g
ene increased at stage I-II-III, decreased at stage IV in the tissues and decreased at each stage (I–IV) in the blood. The mRNA levels of
TTPAL g
ene increased at each stage (I–IV) in the tissues and decreased at each stage (I–IV) in the blood.
Conclusion
Although related expression levels in tissue did not correlate with its expression in blood, consistent with previous studies
FHIT
and
TTPAL
genes upregulation and
CDH1
downregulation, in especially tumoral tissues, may serve as predictive determinants for the patients with colorectal cancer.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.